MEMSCAP, S.A (MEMS) Fair Value & Analysis
Technology · FR · Market cap €44.3M
Fair value as of: Jun 24, 2026
Analysis
MEMSCAP, S.A (MEMS) currently trades at €5.14, while our model-based Fair Value estimate is €2.35 — implying the stock looks roughly 54.3% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
MEMSCAP, S.A. provides micro-electro-mechanical systems (MEMS) based solutions for aerospace and defense, optical communications, medical, and biomedical markets worldwide. It offers pressure sensors, pressure transducers, and pressure switches for various applications, such as air data computers, cabin pressure, engine control, altimeters, barometers, cockpit instruments, and air data test sets. The company also provides gold coated and titanium-based pressure transducers, plastic domes, line-sets, and related accessories. In addition, it supplies MEMS based variable optical attenuator chips in optical power management within fiber telecommunications and data communications networks. Further, the company offers mounting brackets, snap holders, non-sterile and sterile domes, and monitoring line sets. MEMSCAP, S.A. was incorporated in 1997 and is headquartered in Crolles, France.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is MEMSCAP, S.A (MEMS) undervalued?
What is the fair value of MEMS?
What is the quality score of MEMS?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.